Inhaled corticosteroid use and asthma hospitalization rates in Japan

被引:0
|
作者
Odajima, Y
Kuwabara, H
机构
[1] Saitama Med Sch, Dept Paediat, Iruma, Saitama 3500495, Japan
[2] AstraZeneca KK, Osaka, Japan
关键词
inhaled corticosteroids; asthma; epidemiology; hospitalization;
D O I
10.1177/147323000603400211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This epidemiological study assessed whether the use of anti-inflammatory drugs, in particular inhaled corticosteroids, affected hospitalization rates for asthma in Japan between 1990 and 2002. Asthma hospitalization rates were calculated from the number of asthma in-patients recorded in governmental surveys. Information concerning use of anti-inflammatory drugs was extracted from the IMS prescription database. Patients were stratified into four age groups: <= 4 years, 5 - 19 years, 20 39 years and 40 - 64 years. Over the study period, the number of prescriptions for inhaled corticosteroids per year increased dramatically and hospitalizations for asthma decreased in all groups except those <= 4 years of age. Increased use of leukotriene receptor antagonists was also noted in all age groups. The use of anti-inflammatory drugs may have contributed to the observed decrease in asthma hospitalizations. Increased use of inhaled corticosteroids in infants and very young children may help prevent hospitalization in this age group.
引用
收藏
页码:208 / 214
页数:7
相关论文
共 50 条
  • [31] Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma
    Gould, Wendy
    Peterson, Edward L.
    Karungi, Gloria
    Zoratti, Amanda
    Gaggin, John
    Toma, Ghazwan
    Yan, Shiqing
    Levin, Albert M.
    Yang, James J.
    Wells, Karen
    Wang, Mingqun
    Burke, Robert R.
    Beckman, Kenneth
    Popadic, Danijela
    Land, Susan J.
    Kumar, Rajesh
    Seibold, Max A.
    Lanfear, David E.
    Burchard, Esteban G.
    Williams, L. Keoki
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (06) : 1131 - 1138
  • [32] Plasmacytoid dendritic cells in allergic asthma and the role of inhaled corticosteroid treatment
    Bratke, K.
    Prieschenk, C.
    Garbe, K.
    Kuepper, M.
    Lommatzsch, M.
    Virchow, J. C.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2013, 43 (03) : 312 - 321
  • [33] Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
    Wei, Bing
    Dang, Yan-Hong
    Liu, Xiang-Ping
    Li, Miao
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [34] Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden - 1978 to 1991
    Gerdtham, UG
    Hertzman, P
    Jonsson, B
    Boman, G
    MEDICAL CARE, 1996, 34 (12) : 1188 - 1198
  • [35] Ratio of inhaled corticosteroid to bronchodilator treatment and asthma hospitalisation
    Frischer, N
    Heatlie, H
    Chapman, S
    Bashford, J
    Norwood, J
    Millson, D
    CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (01) : 8 - 13
  • [36] The newly developed inhaled corticosteroid ciclesonide for the treatment of asthma
    Colice, Gene L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (15) : 2107 - 2117
  • [37] New regimen of inhaled corticosteroid in preschool children with asthma
    Lim, Dae Hyun
    Kim, Jeong Hee
    Son, Byong Kwan
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2012, 55 (12): : 1201 - 1206
  • [38] Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
    Schaffner, Timothy J.
    Skoner, David P.
    JOURNAL OF ASTHMA AND ALLERGY, 2009, 2 : 25 - 32
  • [39] Inhaled Corticosteroid Therapy in Newly Detected Mild Asthma
    Paul M. O’Byrne
    Drugs, 1999, 58 : 17 - 24